JANE STREET GROUP, LLC - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 76 filers reported holding SILVERBACK THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$81,089
-53.2%
21,452
-17.0%
0.00%
Q2 2023$173,148
-80.6%
25,843
-81.2%
0.00%
Q1 2023$894,800
+433.7%
137,450
+599.2%
0.00%
Q4 2022$167,674
+123.6%
19,657
+38.6%
0.00%
Q3 2022$75,000
-73.3%
14,183
+55.7%
0.00%
Q2 2021$281,000
-68.1%
9,111
-52.1%
0.00%
Q4 2020$882,00019,0380.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Nextech Invest Ltd. 1,910,029$10,085,0003.26%
K2 PRINCIPAL FUND, L.P. 3,247,533$16,890,0001.94%
SECTORAL ASSET MANAGEMENT INC 1,045,234$5,519,0001.09%
Orbimed Advisors 8,740,887$46,152,0000.86%
Rubric Capital Management LP 2,695,170$14,230,0000.72%
Prosight Management, LP 196,257$1,036,0000.56%
Nantahala Capital Management 1,249,863$6,599,0000.43%
Oasis Management Co Ltd. 317,662$1,677,0000.28%
TANG CAPITAL MANAGEMENT LLC 409,463$2,162,0000.26%
APOGEM CAPITAL LLC 13,793$73,0000.07%
View complete list of SILVERBACK THERAPEUTICS INC shareholders